Glis2 is an early effector of polycystin signaling and a target for therapy in polycystic kidney disease
Chao Zhang(Nanjing Tech University), Stefan Somlo(Yale University)
Cited by 22
Related Papers
Mutations in SEC63 cause autosomal dominant polycystic liver disease
|Nature Genetics|2004|282
ERK1/2-Dependent Vascular Endothelial Growth Factor Signaling Sustains Cyst Growth in Polycystin-2 Defective Mice
|Gastroenterology|2009|98
Mammalian Target of Rapamycin Regulates Vascular Endothelial Growth Factor–Dependent Liver Cyst Growth in Polycystin-2–Defective Mice
|Hepatology|2009|95
The Future of Polycystic Kidney Disease Research—As Seen By the 12 Kaplan Awardees
|Journal of the American Society of Nephrology|2015|42